Related references
Note: Only part of the references are listed.Mortality, Length of Stay, and Cost Associated with Hospitalized Adult Cancer Patients with Febrile Neutropenia
Jarin Chindaprasirt et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality
C. Pena et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii
Ilkay Karaoglan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies
George Samonis et al.
SUPPORTIVE CARE IN CANCER (2013)
Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
Laura Morata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy
Felipe F. Tuon et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy
Vered Schechner et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
Kyungwon Lee et al.
YONSEI MEDICAL JOURNAL (2011)
Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection
Cristina Suarez et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections
Cristina Suarez et al.
JOURNAL OF INFECTION (2009)
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pseudomonas aeruginosa serious infections:: Mono or combination antimicrobial therapy?
Matteo Bassetti et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia
H. S. Cheong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Pseudomonas aeruginosa bloodstream infections:: how should we treat'them?
Christian van Delden
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Risk of bacteraemia and mortality in patients with haematological malignancies
M Norgaard et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials
M Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
N Safdar et al.
LANCET INFECTIOUS DISEASES (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia
E Chamot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia:: systematic review and meta-analysis
M Paul et al.
BRITISH MEDICAL JOURNAL (2003)
Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: Clinical outcome and length of hospitalization
S Blot et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
